Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CX-001 by Calissa Therapeutics for Rosacea: Likelihood of Approval
CX-001 is under clinical development by Calissa Therapeutics and currently in Phase II for Rosacea. According to GlobalData, Phase II...
Data Insights
CX-001 by Calissa Therapeutics for Nevus: Likelihood of Approval
CX-001 is under clinical development by Calissa Therapeutics and currently in Phase II for Nevus. According to GlobalData, Phase II...